Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-Profenid for IUD insertion pain
NCT02905058Phase 3
Key facts
- Status
- Completed
- Start
- Oct 2016
- Primary completion
- May 2017
- Countries
- 1
- Sponsor
- Assiut University
- Modality
- Small Molecules
- Drugs
- ketoprofen
- Conditions
- pain
01
Overview
Phase 3, randomised, double-blind trial in pain comparing Ketoprofen Arm with Placebo Arm (2 arms). Primary endpoint: Mean pain score at 5 minutes. Started Oct 2016; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Ketoprofen Arm
Oral Bi-Profenid 150 mg
Placebo Arm
Oral placebo
03
Who it enrols
Women seeking IUD insertion who have not taken analgesics, anxiolytics, or misoprostol in the 24 hours prior to the procedure and have no contraindications to NSAIDs.
04
Endpoints
Primary
Mean pain score
Beyond the preview
Go deeper on NCT02905058.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02905058.